The report highlights the anticipation and apprehension surrounding the upcoming Supreme Court hearing on the constitutional validity of the abrogation of Article 370 and Article 35A in Jammu and Kashmir. The article, which was read down by a Presidential decree in 2019, led to the filing of multiple petitions challenging its legality. The government defended the move, citing improved law and order and development in the region. The hearing, scheduled to begin on August 2, has sparked debates about the future of Jammu and Kashmir, with the outcome expected to have far-reaching implications. The report also explores the arguments and positions of various political figures and petitioners involved in the case.
In the first pan-Jammu, Kashmir Ladakh BOSE results for the tenth class, data speaks so loudly about the changes silently taking place in the school education sector, Masood Hussain and Faiqa Masoodi report Regardless of the politics and the situation, Jammu and Kashmir's school education setup is u.
The adoption system in Kashmir has undergone a significant change, potentially providing a ray of hope for thousands of childless couples. The adoption process has shifted online, and the post-2019 laws no longer recognize foster care but instead offer children for legal adoption. This transformation offers a legitimate avenue for couples to adopt and become legal parents. The online system simplifies the process and ensures transparency, allowing prospective adoptive parents to register and upload relevant documents. With this change, childless couples in Kashmir now have a more accessible and regulated path to fulfill their desire to become parents.
by Faiqa Masoodi SRINAGAR: The researchers from Jamia Millia Islamia’s Multidisciplinary Centre for Advanced Research and Studies (MCARS) have developed therapeutic stem cells to treat lung diseases caused by allergic respiratory inflammation.
by Faiqa Masoodi SRINAGAR: In a major breakthrough, a Kashmiri scientist along with a group of European scientists has discovered a new potential drug for the treatment of metastatic hypoxic cancers. The drug is currently in an advanced stage of further investigations post-animal trials.